When faced with the myriad diseases and equally numerous targets for potential drugs the company could pursue, Kewalramani ...

Come Friday, it will be two years since Julie Zimmer rang the bell at the Mercy Health Springfield Cancer Center to celebrate ...

After ten years, the risk of death was reduced by 17% for people treated with Perjeta ® (pertuzumab), Herceptin ® (trastuzumab) and chemotherapy (the Perjeta-based regimen) for a year as post ...

APHINITY (Adjuvant Pertuzumab and Herceptin IN Initial TherapY in Breast Cancer, NCT01358877/ BO25126/ BIG 4-11) is a global, Phase III, randomized, double-blind, placebo-controlled, two-arm study ...

APHINITY (Adjuvant Pertuzumab and Herceptin IN Initial TherapY in Breast Cancer, NCT01358877 / BO25126/ BIG 4-11) is a global, Phase III, randomized, double-blind, placebo-controlled, two-arm study ...

So, on top of the potential for tissue injury from radiation, long-term heart damage from chemotherapy and issues related to a year of Herceptin, the drugs that she takes to reduce her risk of the ...

Herceptin is a prescription drug used to treat certain kinds of breast and stomach cancer in adults. Learn about side effects and what to do about them.

The main exclusion criteria were history of any invasive malignancy except breast cancer or nonmelanoma skin cancer at least 1 year before random assignment, receipt of previous treatment for MBC or ...

Avoiding Side Effects. HER2-positive breast cancers, which are characterized by amplification of the HER2 gene and overexpression of the HER2 protein, account for 15% of new cases of localized ...

Learn about the history of immunotherapy here. ... (Rituxan) and trastuzumab (Herceptin) were approved during the late 1990s to treat lymphoma and breast cancer, respectively. Monoclonal antibodies ...